Faure F - Search Results

1

Tumor-specific immune response: current in vitro analyses may not reflect the in vivo immune status.

Faure F, Even J, Kourilsky P. Faure F, et al. Crit Rev Immunol. 1998;18(1-2):77-86. doi: 10.1615/critrevimmunol.v18.i1-2.90. Crit Rev Immunol. 1998. PMID: 9419450 Review.

2

The decreased susceptibility of metastatic melanoma cells to killing involves an alteration of CTL reactivity.

Gassara A, Messai Y, Gaudin C, Abouzahr S, Jalil A, Diarra-Mehrpour M, Faure F, Richon C, Avril MF, Even J, Chouaib S. Gassara A, et al. Among authors: faure f. Int J Oncol. 2006 Jul;29(1):155-61. Int J Oncol. 2006. PMID: 16773195

3

Diversity of the cytotoxic melanoma-specific immune response: some CTL clones recognize autologous fresh tumor cells and not tumor cell lines.

Dufour E, Carcelain G, Gaudin C, Flament C, Avril MF, Faure F. Dufour E, et al. Among authors: faure f. J Immunol. 1997 Apr 15;158(8):3787-95. J Immunol. 1997. PMID: 9103444

4

Lymphocyte-activation gene 3/major histocompatibility complex class II interaction modulates the antigenic response of CD4+ T lymphocytes.

Huard B, Tournier M, Hercend T, Triebel F, Faure F. Huard B, et al. Among authors: faure f. Eur J Immunol. 1994 Dec;24(12):3216-21. doi: 10.1002/eji.1830241246. Eur J Immunol. 1994. PMID: 7805750

5

Long-lasting cross-presentation of tumor antigen in human DC.

Faure F, Mantegazza A, Sadaka C, Sedlik C, Jotereau F, Amigorena S. Faure F, et al. Eur J Immunol. 2009 Feb;39(2):380-90. doi: 10.1002/eji.200838669. Eur J Immunol. 2009. PMID: 19130478 Free article.

6

TCR activation of human T cells induces the production of exosomes bearing the TCR/CD3/zeta complex.

Blanchard N, Lankar D, Faure F, Regnault A, Dumont C, Raposo G, Hivroz C. Blanchard N, et al. Among authors: faure f. J Immunol. 2002 Apr 1;168(7):3235-41. doi: 10.4049/jimmunol.168.7.3235. J Immunol. 2002. PMID: 11907077

7

CD1c as a target recognition structure for human T lymphocytes: analysis with peripheral blood gamma/delta cells.

Faure F, Jitsukawa S, Miossec C, Hercend T. Faure F, et al. Eur J Immunol. 1990 Mar;20(3):703-6. doi: 10.1002/eji.1830200336. Eur J Immunol. 1990. PMID: 1690662

8

A novel human V delta gene expressed predominantly in the Ti gamma A fraction of gamma/delta+ peripheral lymphocytes.

Triebel F, Faure F, Mami-Chouaib F, Jitsukawa S, Griscelli A, Genevée C, Roman-Roman S, Hercend T. Triebel F, et al. Among authors: faure f. Eur J Immunol. 1988 Dec;18(12):2021-7. doi: 10.1002/eji.1830181223. Eur J Immunol. 1988. PMID: 2975601

9

Evidence for in situ amplification of cytotoxic T-lymphocytes with antitumor activity in a human regressive melanoma.

Mackensen A, Ferradini L, Carcelain G, Triebel F, Faure F, Viel S, Hercend T. Mackensen A, et al. Among authors: faure f. Cancer Res. 1993 Aug 1;53(15):3569-73. Cancer Res. 1993. PMID: 8339262

10

In situ T-cell responses in a primary regressive melanoma and subsequent metastases: a comparative analysis.

Carcelain G, Rouas-Freiss N, Zorn E, Chung-Scott V, Viel S, Faure F, Bosq J, Hercend T. Carcelain G, et al. Among authors: faure f. Int J Cancer. 1997 Jul 17;72(2):241-7. doi: 10.1002/(sici)1097-0215(19970717)72:2<241::aid-ijc7>3.0.co;2-r. Int J Cancer. 1997. PMID: 9219827

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

203 results

Search Page

Filters